Creative Medical Technology (CELZ) Projected to Post Quarterly Earnings on Friday

Creative Medical Technology (NASDAQ:CELZ) is anticipated to release its earnings data before the market opens on Friday, March 28th. Analysts expect Creative Medical Technology to post earnings of ($0.63) per share for the quarter.

Creative Medical Technology Stock Performance

Shares of NASDAQ CELZ opened at $2.21 on Thursday. Creative Medical Technology has a 1 year low of $1.92 and a 1 year high of $6.90. The stock’s 50-day simple moving average is $3.78 and its 200-day simple moving average is $3.24. The firm has a market cap of $3.86 million, a price-to-earnings ratio of -0.58 and a beta of 1.70.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.